CXCR4 antagonist (Polyphor investigational)

CXCR4 antagonist · Polyphor Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CXCR4 antagonist (Polyphor investigational), covering 2016-06-10 to 2016-06-10. Get the full timeline:

Most recent: Clinical Trial Update: CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI) [Phase 2]